Kindstar Globalgene Technology, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 967.26 million compared to CNY 1,386.59 million a year ago. Net income was CNY 41.29 million compared to CNY 75.46 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0431 compared to CNY 0.0949 a year ago. Diluted earnings per share from continuing operations was CNY 0.0425 compared to CNY 0.0922 a year ago.